New Zealand markets open in 1 hour 33 minutes

Well Lead Medical Co., Ltd. (603309.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
11.91-0.11 (-0.92%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 3.52B
Enterprise value 3.52B
Trailing P/E 18.49
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.64
Price/book (mrq)1.89
Enterprise value/revenue 2.64
Enterprise value/EBITDA 14.85

Trading information

Stock price history

Beta (5Y monthly) -0.22
52-week change 3-36.03%
S&P500 52-week change 324.78%
52-week high 319.15
52-week low 38.52
50-day moving average 311.70
200-day moving average 312.65

Share statistics

Avg vol (3-month) 34.13M
Avg vol (10-day) 33.44M
Shares outstanding 5293.16M
Implied shares outstanding 6295.87M
Float 8141.77M
% held by insiders 157.55%
% held by institutions 110.12%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.5
Forward annual dividend yield 44.20%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 34.16%
5-year average dividend yield 41.31
Payout ratio 452.31%
Dividend date 3N/A
Ex-dividend date 423 May 2024
Last split factor 21.3:1
Last split date 325 May 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 14.28%
Operating margin (ttm)20.59%

Management effectiveness

Return on assets (ttm)5.17%
Return on equity (ttm)10.82%

Income statement

Revenue (ttm)1.34B
Revenue per share (ttm)4.55
Quarterly revenue growth (yoy)-14.50%
Gross profit (ttm)N/A
EBITDA 271.19M
Net income avi to common (ttm)190.64M
Diluted EPS (ttm)0.65
Quarterly earnings growth (yoy)-3.50%

Balance sheet

Total cash (mrq)663.8M
Total cash per share (mrq)2.26
Total debt (mrq)672.97M
Total debt/equity (mrq)35.62%
Current ratio (mrq)1.77
Book value per share (mrq)6.37

Cash flow statement

Operating cash flow (ttm)193.24M
Levered free cash flow (ttm)-279.81M